Botanix Pharmaceuticals Limited(AU:BOT)
A$0.010.00 (0.00%)
AU:BOT
Botanix Pharmaceuticals Limited financials statements
A$0.01
At close:0.00 (0.00%)
Want to see AU:BOT full AI Analyst Report?
Botanix Pharmaceuticals Limited (BOT) Ratios
173 Followers
Botanix Pharmaceuticals Limited Ratios
AU:BOT's free cash flow for Q4 2026 was AU$-31.95M. For the 2026 fiscal year, AU:BOT's free cash flow was increased by AU$2.27K and operating cash flow was AU$-31.96M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.59 | 4.00 | 22.21 | 7.42 | 1.78 |
| Quick Ratio | 1.58 | 2.87 | 21.89 | 5.75 | 1.27 |
| Cash Ratio | 1.18 | 2.61 | 21.25 | 5.44 | 1.24 |
| Solvency Ratio | -1.64 | -1.76 | -3.70 | -4.80 | -2.21 |
| Operating Cash Flow Ratio | -2.09 | -3.15 | -2.18 | -6.41 | -1.90 |
| Short-Term Operating Cash Flow Coverage | -4.52 | -8.51 | 0.00 | 0.00 | -91.36 |
| Net Current Asset Value | AU$ 37.82M | AU$ 51.79M | AU$ 79.17M | AU$ 12.09M | AU$ 4.62M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.14 | 0.25 | 0.00 | 0.00 | 0.01 |
| Debt-to-Equity Ratio | 0.23 | 0.40 | 0.00 | 0.00 | 0.02 |
| Debt-to-Capital Ratio | 0.19 | 0.29 | 0.00 | 0.00 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.21 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.67 | 1.59 | 1.03 | 1.08 | 1.72 |
| Debt Service Coverage Ratio | -4.05 | -5.52 | -1293.41 | -109.65 | -81.26 |
| Interest Coverage Ratio | -24.43 | -15.05 | -1475.97 | -156.55 | -425.78 |
| Debt to Market Cap | 0.35 | 0.05 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.32 | 0.40 | 5.20 | 0.81 | 0.45 |
| Profitability Margins | |||||
| Gross Profit Margin | -172.20% | 34.85% | -1016.72% | -332.91% | -273.60% |
| EBIT Margin | -200.82% | -1432.23% | -2546.73% | -1392.57% | -576.70% |
| EBITDA Margin | -200.82% | -1393.13% | -2534.66% | -1380.50% | -571.51% |
| Operating Profit Margin | -200.82% | -1395.62% | -2614.12% | -1398.49% | -578.62% |
| Pretax Profit Margin | -202.15% | -1492.37% | -2304.68% | -1401.46% | -578.08% |
| Net Profit Margin | -202.15% | -1492.37% | -2304.68% | -1000.47% | -478.08% |
| Continuous Operations Profit Margin | -202.15% | -1492.37% | -2304.68% | -1000.47% | -478.08% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 71.39% | 82.70% |
| EBT Per EBIT | 100.66% | 106.93% | 88.16% | 100.21% | 99.91% |
| Return on Assets (ROA) | -65.83% | -66.92% | -12.33% | -36.86% | -93.83% |
| Return on Equity (ROE) | -109.83% | -106.27% | -12.76% | -39.88% | -161.57% |
| Return on Capital Employed (ROCE) | -92.42% | -77.56% | -14.47% | -55.75% | -195.55% |
| Return on Invested Capital (ROIC) | -77.62% | -70.96% | -12.94% | -39.80% | -157.01% |
| Return on Tangible Assets | -86.03% | -85.57% | -16.72% | -64.89% | -122.61% |
| Earnings Yield | -169.61% | -14.63% | -2.93% | -6.10% | -23.74% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.20 | 2.03 | 0.74 | 1.87 | 19.56 |
| Payables Turnover | 16.03 | 0.43 | 2.62 | 2.85 | 2.20 |
| Inventory Turnover | 3.00 | 0.13 | 5.91 | 1.26 | 3.38 |
| Fixed Asset Turnover | 42.26 | 4.18 | 8.38 | 14.00 | 15.37 |
| Asset Turnover | 0.33 | 0.04 | 0.01 | 0.04 | 0.20 |
| Working Capital Turnover Ratio | 0.56 | 0.08 | 0.01 | 0.11 | 0.22 |
| Cash Conversion Cycle | 169.27 | 2038.66 | 418.02 | 356.96 | -39.41 |
| Days of Sales Outstanding | 70.24 | 179.89 | 495.53 | 195.12 | 18.66 |
| Days of Inventory Outstanding | 121.80 | 2717.11 | 61.71 | 289.99 | 107.96 |
| Days of Payables Outstanding | 22.77 | 858.35 | 139.22 | 128.15 | 166.03 |
| Operating Cycle | 192.04 | 2897.01 | 557.24 | 485.11 | 126.62 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.03 | -0.04 | -0.01 | -0.01 | -0.01 |
| Free Cash Flow Per Share | -0.03 | -0.04 | -0.02 | -0.02 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -21532174.33 | -274.36 | -0.45 | -1.71 | -3.83 |
| Capital Expenditure Coverage Ratio | -21532174.33 | -274.36 | -0.45 | -1.71 | -3.83 |
| Operating Cash Flow Coverage Ratio | -4.38 | -2.42 | 0.00 | 0.00 | -91.36 |
| Operating Cash Flow to Sales Ratio | -1.87 | -13.57 | -13.50 | -13.20 | -4.06 |
| Free Cash Flow Yield | -157.04% | -13.36% | -5.52% | -12.75% | -25.43% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.59 | -6.84 | -34.10 | -16.39 | -4.21 |
| Price-to-Sales (P/S) Ratio | 1.19 | 101.98 | 785.94 | 163.95 | 20.13 |
| Price-to-Book (P/B) Ratio | 0.65 | 7.26 | 4.35 | 6.54 | 6.80 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.64 | -7.49 | -18.10 | -7.84 | -3.93 |
| Price-to-Operating Cash Flow Ratio | -0.64 | -7.51 | -58.20 | -12.42 | -4.96 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | -0.02 | -2.07 | 0.40 | -0.01 |
| Enterprise Value Multiple | -0.28 | -6.92 | -25.81 | -11.06 | -3.07 |
| Enterprise Value | 19.24M | 557.94M | 393.68M | 139.76M | 48.31M |
| EV to EBITDA | -0.28 | -6.92 | -25.81 | -11.06 | -3.07 |
| EV to Sales | 0.56 | 96.38 | 654.16 | 152.75 | 17.53 |
| EV to Free Cash Flow | -0.30 | -7.07 | -15.07 | -7.31 | -3.42 |
| EV to Operating Cash Flow | -0.30 | -7.10 | -48.44 | -11.58 | -4.32 |
| Tangible Book Value Per Share | 0.02 | 0.03 | 0.05 | 0.01 | 0.00 |
| Shareholders’ Equity Per Share | 0.03 | 0.04 | 0.07 | 0.02 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.11 | 0.29 | 0.17 |
| Revenue Per Share | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.03 | -0.05 | -0.01 | -0.01 | -0.01 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.71 | 0.83 |
| Interest Burden | 1.01 | 1.04 | 0.90 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.02 | 3.01 | 6.26 | 3.74 |
| SG&A to Revenue | 0.29 | 14.28 | 11.05 | 3.32 | 0.39 |
| Stock-Based Compensation to Revenue | 0.00 | 3.54 | 7.30 | 1.66 | 0.12 |
| Income Quality | 0.93 | 0.91 | 0.59 | 1.32 | 0.85 |
Currency in AUD
